EMA To Update Active Substances Guide To Address Nitrosamine Contamination
Executive Summary
The European Medicines Agency wants to make it clearer for drug sponsors what more they can do to address the presence of cancer-causing impurities in active substances, and how to deal with the issue in their regulatory submissions.